Cardiovascular pharmacotherapeutics / edited by William H. Frishman, Edmund H. Sonnenblick, Domenic A. Sica.
Publication details: New York : McGraw-Hill, Medical Pub. Division, c2003.Edition: 2nd editionDescription: xxiv, 1072 p. : ill. ; 29 cmISBN:- 0071369813
- QV 150 C2678 2003
Item type | Current library | Call number | Copy number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Book Open Access | Health Sciences Library | QV 150 C2678 2003 (Browse shelf(Opens below)) | 1 | Available | MBAL22020911 |
Browsing Health Sciences Library shelves Close shelf browser (Hides shelf browser)
QV 13 E56 1999 Vol.2 Encyclopedia of controlled drug delivery / | QV 13 M431e 1999 Encyclopedia of controlled drug delivery / | QV 13 P348 1997 PDR guide to drug interactions, side effects, Indications, contradications / | QV 150 C2678 2003 Cardiovascular pharmacotherapeutics / | QV 16 S874p 1986 Pharmaceutical calculations / | QV 17 L989I 2008 Lippincott's photo atlas of medication administration / | QV 17 L989I 2008 Lippincott's photo atlas of medication administration / |
Includes bibliographical references and index.
Part 1 Introductory Chapters
1. Basic Principles
2. Placebo Effect
3. Compliance
4. New Drug Development
5. Pharmacoeconomics
6. Cardiovascular Pharm History
Part 2 Drug Classes
7. Alpha & Beta blockers
8. Cholinergic & Anticholinergic Drugs
9. Calcium blockers
10. RAS – ACE, ARBs
11. Diuretic
12. Mag, K+, Calcium
13. Digitalis and Inotropic Agents
14. Organic Nitrates and nitroprusside
15. Central Action, Ganglionic blockers, neuron depletors
16. Nonspecific antihypertensive vasodilators
17. Antiarrhythmics
18. Antiplatelets & Antithrombotics
19. Thrombolytics
20. Lipid lowering/effects of CV drugs on lipoproteins
21. Combination
22. Smoking, nicotine
23. Fish oils
24. Antioxidant vitamins and free radical scavengers
25. Prostacyclin
26. Dopamine
Part 3 New Drugs Classes in Development
27. Natriuretic peptides and neutral endopeptidase
28. Potassium channel and sodium-hydrogen channel
29. Serotonin
30. Imidazoline
31. Endothelin
32. Adenosine
33. Nitric oxide
34. Renin
35. Vasopressin
36. Hormones
37. Innovative approaches for myocardial ischemia – focus on angiogenesis
38. Angiogenesis
39. Innovative drug targets
40. Restenosis
41. Gene therapy
42. Apoptosis
43. Matrix Metalloproteinase
44. NSAIDS & Cox 2 inhibitors
45. Prostaglandins & P450 Metabolites
46. Innovative med. approaches to hyperlipidemia
There are no comments on this title.